Cantor Boosts PT on Syneron Medical (ELOS); Sees Tough Q4, But FY4 Should Fare Well
Tweet Send to a Friend
Cantor Fitzgerald boosts its price target on Syneron Medical Ltd. (Nasdaq: ELOS) from $15 up to $18 while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
